Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-14 May, 2026
Gynecology and Obstetr...Gynecology and Obstetrics
Not Confirmed
Not Confirmed
11-12 May, 2026
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-14 May, 2026
Gynecology and Obstetr...Gynecology and Obstetrics
Industry Trade Show
Not Confirmed
11-12 May, 2026
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
Digital content

06 May 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-announce-first-quarter-2026-financial-results-and-business-update-on-may-13-2026-302763976.html

11 Mar 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-announce-fiscal-year-2025-financial-results-and-business-update-on-march-18-2026-302710843.html

09 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/09/3251619/0/en/Chiesi-Global-Rare-Diseases-and-Protalix-BioTherapeutics-Announce-European-Commission-Approval-of-Additional-Dosing-Regimen-of-Every-Four-Weeks-for-Elfabrio-pegunigalsidase-alfa.html

30 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/30/3229591/0/en/Chiesi-Global-Rare-Diseases-and-Protalix-BioTherapeutics-Receive-Positive-CHMP-Opinion-for-an-Additional-Dosing-Regimen-of-Every-Four-Weeks-for-Elfabrio-pegunigalsidase-alfa-in-the.html

05 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-letter-to-stockholders-302652582.html

17 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/protalix-biotherapeutics-and-secarna-pharmaceuticals-enter-into-collaboration-and-option-agreement-302644533.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
Protalix BioTherapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find Taliglucerase Alfa bulk offered by Protalix BioTherapeutics